Production of Anti-Dandruff Shampoo Nizoral to Begin in Sabac – Hemofarm Opens New Facility Worth EUR 10 Million

A new production line of the company Hemofarm, in which EUR 10 million was invested, has opened in Sabac.

– By investing in the reconstruction of an old blister pack department and procuring new production equipment for five new production lines, Hemofarm is expanding its portfolio and commencing the production of the world-renowned brand Nizoral, an anti-dandruff shampoo – the press release says.

It is added that the German Stada Group, of which Hemofarm is a member, bought the production portfolio of the Nizoral shampoos from the company Johnson&Johnson in 2019 and made the decision to move the production to Hemofarm’s facility in Sabac.

The first phase of the reconstruction of the facility in Sabac was completed in June 2022, when the production lines were put into operation.

Jesus Corchero Romero, the senior vice president of Stada Group for global operations, said that, following the full reconstruction, the facility would have three lines for the production of liquid, three lines for pouring the liquid into bottles and one for pouring the liquid into small bags, which also creates the opportunity for new jobs.

So far, the validation of five different formulas of Nizoral 2% shampoo has been completed, and in December, the preparation of the optimization series of the Nizoral 1% shampoo began, the press release says.

– After the reconstruction is completed, the total production capacity will amount to 30 million liquid form packs – said Dejan Ivanovic, the director of operations of Hemofarm Group.

At the moment, at the Hemofarm factory in Sabac, 7 million liquid form packs are produced, and when all the transfers of this investment are completed, the annual production will amount to 37 million liquid form packs, the press release concludes.

Hemofarm a.d. Vršac

Stada Group

Nizoral anti dandruff shampoo

Johnson Johnson

Dejan Jovanović

Jesus Corchero Romero

new facility

new production line

investment in Sabac